☰

Trudy Gaillard, Ph.D. - Publications

Affiliations: 
2005 Ohio State University, Columbus, Columbus, OH 
Area:
Public Health, Recreation, Biochemistry, Black Studies
Tree Info Similar researchers PubMed Report error

41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Gaillard T, Chen H, Effoe VS, Correa A, Carnethon M, Kalyani RR, Echouffo-Tcheugui JB, Joseph JJ, Bertoni AG. Glucometabolic State Transitions: The Jackson Heart Study. Ethnicity & Disease. 32: 203-212. PMID 35909644 DOI: 10.18865/ed.32.3.203  0.339
2018 Osei K, Gaillard T. Pathogenic mechanisms of prediabetes in obese vs. very obese African American women: Implications for diabetes prevention. Journal of the National Medical Association. PMID 30032866 DOI: 10.1016/j.jnma.2018.06.004  0.323
2017 Gaillard TR. The Metabolic Syndrome and Its Components in African-American Women: Emerging Trends and Implications. Frontiers in Endocrinology. 8: 383. PMID 29403438 DOI: 10.3389/fendo.2017.00383  0.413
2017 Osei K, Gaillard T. Disparities in Cardiovascular Disease and Type 2 Diabetes Risk Factors in Blacks and Whites: Dissecting Racial Paradox of Metabolic Syndrome. Frontiers in Endocrinology. 8: 204. PMID 28912752 DOI: 10.3389/Fendo.2017.00204  0.448
2017 Osei K, Gaillard T. Ethnic differences in glucose effectiveness and disposition index in overweight/obese African American and white women with prediabetes: A study of compensatory mechanisms. Diabetes Research and Clinical Practice. PMID 28629856 DOI: 10.1016/J.Diabres.2017.02.020  0.499
2016 Gaillard T, Osei K. Ethnic differences in serum lipids and lipoproteins in overweight/obese African-American and white American women with pre-diabetes: significance of NMR-derived lipoprotein particle concentrations and sizes. Bmj Open Diabetes Research & Care. 4: e000246. PMID 27547417 DOI: 10.1136/Bmjdrc-2016-000246  0.458
2016 Gaillard TR, Osei K. Racial Disparities in the Pathogenesis of Type 2 Diabetes and its Subtypes in the African Diaspora: A New Paradigm. Journal of Racial and Ethnic Health Disparities. 3: 117-28. PMID 26896111 DOI: 10.1007/s40615-015-0121-z  0.375
2016 Fessel K, Gaither JB, Bower JK, Gaillard T, Osei K, Rempala GA. Mathematical analysis of a model for glucose regulation. Mathematical Biosciences and Engineering : Mbe. 13: 83-99. PMID 26776262 DOI: 10.3934/Mbe.2016.13.83  0.516
2015 Gaillard T, Amponsah G, Osei K. Patient-Centered Community Diabetes Education Program Improves Glycemic Control in African-American Patients with Poorly Controlled Type 2 Diabetes: Importance of Point of Care Metabolic Measurements. Journal of National Black Nurses' Association : Jnbna. 26: 50-7. PMID 26371360  0.335
2015 Healy SJ, Osei K, Gaillard T. comparative study of glucose homeostasis, lipids and lipoproteins, HDL functionality, and cardiometabolic parameters in modestly severely obese African Americans and White Americans with prediabetes: implications for the metabolic paradoxes. Diabetes Care. 38: 228-35. PMID 25524949 DOI: 10.2337/Dc14-1803  0.517
2015 Dungan KM, Osei K, Gaillard T, Moore J, Binkley P. A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbation. Diabetes/Metabolism Research and Reviews. 31: 93-101. PMID 24916838 DOI: 10.1002/Dmrr.2569  0.458
2015 Gaillard T, Osei K. Effects of diet-induced weight loss on the cardiometabolic markers in obese African American and white women with prediabetes Journal of Obesity and Metabolic Research. 2: 147. DOI: 10.4103/2347-9906.162335  0.539
2014 Gaillard T. Consequences of Abdominal Adiposity within the Metabolic Syndrome Paradigm in Black People of African Ancestry. Journal of Clinical Medicine. 3: 897-912. PMID 26237484 DOI: 10.3390/Jcm3030897  0.479
2013 Stakos DA, Boudoulas KD, Gaillard TR, Schuster DP, Osei K, Boudoulas H. Regional and overall aortic function in nondiabetic individuals with insulin resistance and normal glucose tolerance. The Journal of Clinical Endocrinology and Metabolism. 98: 4457-63. PMID 24064690 DOI: 10.1210/Jc.2013-2276  0.419
2012 Gaillard TR, Schuster D, Osei K. Characterization of metabolically unhealthy overweight/obese African American women: significance of insulin-sensitive and insulin-resistant phenotypes. Journal of the National Medical Association. 104: 164-71. PMID 22774383 DOI: 10.1016/S0027-9684(15)30141-3  0.454
2011 Gaillard T, Parthasarathy S, Osei K. HDL dysfunctionality (Paraoxonase) is worse in nondiabetic, postmenopausal African American than in white women. Diabetes Care. 34: e19. PMID 21270177 DOI: 10.2337/Dc10-1189  0.383
2011 Gaillard T, Parthasarathy S, Osei K. Response to Comment on: Gaillard et al. HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women. Diabetes Care 2011;34:e19 Diabetes Care. 34: e151-e151. DOI: 10.2337/Dc11-1176  0.417
2010 Gaillard T, Schuster D, Osei K. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome. Metabolism: Clinical and Experimental. 59: 1115-23. PMID 20051282 DOI: 10.1016/J.Metabol.2009.09.035  0.563
2010 Rivas A, Landon M, Gaillard T, Schuster D, Osei K. Awareness of risk factors for type 2 diabetes in women with current and former gestational diabetes mellitus (GDM): Implications for future primary diabetes prevention Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 4: 89-94. DOI: 10.1016/J.Dsx.2010.05.007  0.393
2010 Gaillard T. Insulin Resistance and Cardiovascular Disease Risk in Black People of the African Diaspora Current Cardiovascular Risk Reports. 4: 186-194. DOI: 10.1007/S12170-010-0092-X  0.497
2009 Gaillard T, Schuster D, Osei K. Independent role of blood pressure on cardiovascular risk factors in nondiabetic, obese African-American women with family history of type 2 diabetes: Implications for metabolic syndrome components. Journal of the American Society of Hypertension : Jash. 3: 25-34. PMID 20409942 DOI: 10.1016/J.Jash.2008.07.003  0.467
2009 Gaillard T, Schuster D, Osei K. Metabolic syndrome in Black people of the African diaspora: the paradox of current classification, definition and criteria. Ethnicity & Disease. 19: S2-1-7. PMID 19537240  0.375
2008 Winnick JJ, Gaillard T, Schuster DP. Resistance training differentially affects weight loss and glucose metabolism of White and African American patients with type 2 diabetes mellitus. Ethnicity & Disease. 18: 152-6. PMID 18507266  0.387
2007 Schuster DP, Gaillard T, Osei K. The cardiometabolic syndrome in persons of the African diaspora: challenges and opportunities. Journal of the Cardiometabolic Syndrome. 2: 260-6. PMID 18059209 DOI: 10.1111/J.1559-4564.2007.07484.X  0.551
2007 Gaillard TR, Sherman WM, Devor ST, Kirby TE, Osei K. Importance of aerobic fitness in cardiovascular risks in sedentary overweight and obese African-American women. Nursing Research. 56: 407-15. PMID 18004187 DOI: 10.1097/01.Nnr.0000299851.67676.34  0.65
2007 Osei K, Gaillard T, Schuster D. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone. Metabolism: Clinical and Experimental. 56: 24-9. PMID 17161222 DOI: 10.1016/J.Metabol.2006.08.018  0.543
2007 Gaillard T. Faith-Based Adult Learning Initiatives for Diabetes Education in the African American Community. Adult Learning. 18: 6-8. DOI: 10.1177/104515950701800102  0.472
2006 Meis SB, Schuster D, Gaillard T, Osei K. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox. Ethnicity & Disease. 16: 830-6. PMID 17061734 DOI: 10.13016/Mnab-L8Kn  0.577
2005 Osei K, Gaillard T, Schuster D. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Obesity Research. 13: 179-85. PMID 15761178 DOI: 10.1038/Oby.2005.23  0.553
2004 Osei K, Gaillard T, Kaplow J, Bullock M, Schuster D. Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes. Metabolism: Clinical and Experimental. 53: 1552-7. PMID 15562399 DOI: 10.1016/J.Metabol.2004.06.023  0.556
2004 Schuster D, Gaillard T, Rhinesmith S, Habash D, Osei K. Impact of metformin on glucose metabolism in nondiabetic, obese African Americans: a placebo-controlled, 24-month randomized study. Diabetes Care. 27: 2768-9. PMID 15505024 DOI: 10.2337/Diacare.27.11.2768  0.503
2004 Osei K, Rhinesmith S, Gaillard T, Schuster D. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care. 27: 1439-46. PMID 15161801 DOI: 10.2337/Diacare.27.6.1439  0.534
2004 Osei K, Rhinesmith S, Gaillard T, Schuster D. Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes. Metabolism: Clinical and Experimental. 53: 414-22. PMID 15045685 DOI: 10.1016/J.Metabol.2003.11.016  0.563
2003 Osei K, Rhinesmith S, Gaillard T, Schuster D. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes? The Journal of Clinical Endocrinology and Metabolism. 88: 4596-601. PMID 14557428 DOI: 10.1210/Jc.2003-030686  0.554
2003 Schuster D, Gaillard T, Rhinesmith S, Habash D, Osei K. The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study. Metabolism-Clinical and Experimental. 52: 1211-1217. PMID 14506629 DOI: 10.1016/S0026-0495(03)00160-4  0.586
2003 Amoah AGB, Schuster DP, Gaillard T, Osei K. Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians Diabetologia. 46: 949-955. PMID 12819902 DOI: 10.1007/S00125-003-1130-8  0.477
2003 Osei K, Rhinesmith S, Gaillard T, Schuster D. Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action. Metabolism: Clinical and Experimental. 52: 565-72. PMID 12759885 DOI: 10.1053/Meta.2003.50111  0.573
2002 Amoah AG, Schuster DP, Gaillard T, Osei K. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance. Ethnicity & Disease. 12: S3-10-7. PMID 12477148  0.501
1999 Osei K, Gaillard T, Schuster DP. Significance of parental history of type 2 diabetes on insulin sensitivity and glucose effectiveness in obese nondiabetic offspring of African-American patients. Diabetes Care. 22: 1594-1596. PMID 10480538 DOI: 10.2337/Diacare.22.9.1594  0.565
1999 Osei K, Gaillard T, Schuster DP. Cardiovascular risk factors in African-Americans with varying degrees of glucose intolerance. Diabetes Care. 22: 1588-1590. PMID 10480533 DOI: 10.2337/Diacare.22.9.1588  0.477
1997 Osei K, Gaillard T, Schuster DP. Pathogenetic Mechanisms of Impaired Glucose Tolerance and Type II Diabetes in African-Americans: The significance of insulin secretion, insulin sensitivity, and glucose effectiveness Diabetes Care. 20: 396-404. PMID 9051394 DOI: 10.2337/Diacare.20.3.396  0.53
Show low-probability matches.